Zymeworks Announces $200M Share Repurchase Program
Zymeworks authorized up to $200 million in share repurchases, planning to spend $140 million through 2028. The move enhances shareholder returns by reducing the share count while maintaining flexibility for future capital allocation.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed